期刊文献+

1型糖尿病对血脂代谢及肾和心脏组织结构的影响

Lipid abnormalities,renal and cardiac histology changes in rabbits with type 1 diabetes
下载PDF
导出
摘要 目的探讨1型糖尿病对血脂代谢及肾和心脏组织结构的影响。方法随机选取新西兰大白兔36只,分为糖尿病组(DM,20只)和对照组(NC,16只),两次四氧嘧啶(ALX,80mg/kg)耳缘静脉注射复制1型糖尿病模型,期间进行血糖控制。饲养4周,观察兔一般情况,4周末采血检测血脂变化,包括TG、TC、LDL-C、HDL-C水平、载脂蛋白(Apo)A1、ApoB100、ApoE,处死兔后膀胱穿刺抽取尿液检测尿常规和尿蛋白定量,分离心脏和肾脏进行病理组织检查。结果实验造模成功率为55%,死亡率为40%。DM组TC、HDL-C、LDL-C水平显著高于NC组(P<0.01),其中TC、TG、LDL-C水平较NC组分别升高97%,48%,130%。DM组TC/HDL-C,LDL-C/HDL-C水平高于NC组(P<0.01),但TG/HDL-C水平低于NC组;两组ApoB 100、ApoA1/ApoB100、ApoE差异无统计学意义(均P>0.05)。DM组尿蛋白定量较NC组升高。DM组心肌病理检查出现轻度-中-重度不同程度的心内膜下脂肪变性和沉积,肾脏病理检查提示肾小球血管袢分叶数量增加,基底膜及系膜基质增生,肾小球体积缩小,部分出现脂肪变替代,肾小管出现不同程度范围变性甚至坏死,腔内可见钙盐沉积。结论 1型糖尿病可导致脂质代谢紊乱,引起心脏和肾脏病变,需行积极降脂治疗。 Objective To investigate the changes of lipid metabolism, renal and cardiac histology in type 1 diabetes. Methods Thirty six New Zealand rabbits were randomly divided into diabetes mel itus group (DM, n=20) and normal control group (NC, n=16). Type 1 diabetes was induced by injection of Al oxan(80mg/kg) twice via ear marginal venous, the same vol-ume of normal saline was injected in NC group. The general conditions, body weight, food and water intake were observed for 4 weeks after injection; blood total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL- C), high density lipoprotein cholesterol(HDL- C), apolipoprotein A(apoA), apolipoprotein B(apoB) and apolipoprotein E(apoE) levels were deter-mined, and routine urine test, urine protein were measured by the end of the experiment; and histopathological examination of heart and renal were performed. Results The TC, HDL- C, LDL- C levels and TC/HDL- C, LDL- C/HDL- C in DM group were significantly higher than those in NC group (P〈0.01), but there was no significant difference in ApoB100 levels and ApoA1/ApoB100 between two groups. Compared to NC group the levels of TC, TG, LDL- C in DM group were elevated by 97%, 48%and 130%, respectively;there were no statistical differences in the ratio of TG/HDL- C and ApoE level between two groups. The urine protein level in DM group was higher than that in NC group. Histopathological examination showed that there were cel edema, disordered arrangement of myocardial fibers, interstitial enlargement, mild- moderate- severe lipid accumulation and fatty degeneration under the epicardium in the heart of DM group. Basement membrane and mesangial matrix proliferation, glomerular volume shrinking and glomerular fatty degeneration, mild- moderate- severe tubular degeneration and necrosis, cal-cium salt deposits were observed in the cavity of distal convoluted tubule in diabetic kidney. Conclusion Type 1 diabetes may result in dyslipidemia and heart and kidney dysfunction, which are associated with pathogenesis of diabetic nephropathy and cardiomyopathy.
出处 《浙江医学》 CAS 2014年第21期1760-1763,I0001,共5页 Zhejiang Medical Journal
基金 浙江省自然科学基金资助项目(Y2110934)
关键词 糖尿病 高脂血症 糖尿病肾病 糖尿病心肌病 Diabetes mel itus Lipid abnormality Diabetic nephropathy Diabetic cardiomyopathy
  • 相关文献

参考文献18

  • 1Maahs D M, Dabelea D, D'Agostino R B Jr, et al. Glucose control predicts 2-year change in lipid profile in youth with type 1 dia- betes[J]. J Pediatr,2013,162(1):101-107.
  • 2Maahs D M, Wadwa R P, Bishop F, et al. Dyslipidemia in youth with diabetes: to treat or not to treat[J].? J Pediatr, 2008, 153(4):458- 465.
  • 3Renard C B, Kramer F, Johansson F, et al. Diabetes and dia- betes-associated lipid abnormalities have distinct effects on initi- ation and progression of atherosclerotic lesions[J]. J Clin Invest, 2004,114(5):659-668.
  • 4Johansson F, Kramer F, Barnhart S, et al. Type 1 diabetes pro- motes disruption of advanced atherosclerotic lesions in LDL-C receptor-deficient mice[J]. Proc Natl Acad Sci U S A, 2008, 105 (6):2082-2087.
  • 5The Diabetes Control and Complications Trial Research Group. The effects of intensive treatment of diabetes on the development and progression of long-term complications of insulin-depen-dent diabetes mellitus[J]. N Engl J Med, 1993, 329(14):977-986.
  • 6The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascu- lar events and risk factors in the diabetes control and complica- tions trial[J]. Am J Cardiol,1995,75:894-903.
  • 7Maahs D M, Ogden L G, Dabelea D, et al. Association of gly- caemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medication[J]. Diabetologia, 2010, 53(12): 2518- 2525.
  • 8de Boer I H, Kestenbaum B, Rue T C, et al. Insulin therapy, hyper- glycemia, and hypertension in type 1 diabetes mellitus[J]. Arch Intern Med, 2008,168:1867-1873.
  • 9Nathan D M, Cleary P A, Backlund J Y, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 dia- betes[J]. N Engl J Med,2005,353:2643-2653.
  • 10Teramoto T, Shirai K, Daida H,et al. Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study[J]. Cardiovasc Diabetol, 2012, 11:29-39.

二级参考文献20

  • 1艾静,王宁,杜杰,杨梅,刘萍,杜智敏,杨宝峰.Wistar大鼠2型糖尿病动物模型的建立[J].中国药理学通报,2004,20(11):1309-1312. 被引量:33
  • 2徐淑云,卞如濂,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2002:1346-1347
  • 3Wentao S,Chunling L,Sihai Z,et al.Optimized alloxan-induced diabetic rabbit model[J].lnt J Ophthalmol,2010,10(10):1848- 185O.
  • 4Jolanda M,van Golde J M,Ruiter M S,et al.lmpaired collateral re- cruitment and outward remdeling in experimental diabetes[J].Di- abetes,2008,57(10):2818-2823.
  • 5Lenzen S.The mechanisms of alloxan and streptozotocin in- Juced diabetes[J].Diabetologia,2008,51 (2):216-226.
  • 6Lenzen S.The mechanisma of alloxan-and streptozotoein-in- duced diabetes[J].Diabetologia,2008,51:216-226.
  • 7Casis O, Echevarria E. Diabetic cardiomyopathy electromechanicalcellular alterations [ J ].Curr Vasc Pharmaco1,2004,2 : 237- 248.
  • 8Rossing P, Breum L, Major-Pedersen A, et al.Prolonged QTc inter- val predicts mortality in patients with Type 1 diabetes mellitus [ J], Diabet Med,2001,18 : 199- 205.
  • 9Frothingham R.Rates of torsades de pointes associated with cipro- floxacin, ofloxaein, levofloxaein, gatifloxaein, and moxifloxacin [ J ]. Pharmacotherapy ,2001,21 : 1468-1472.
  • 10Yan GX, Shimizu W, Antzelevitch C. Characteristics and distribu- tion of M cells inarterially perfused canine left ventricular wedge preparations [ J ].Circulation, 1998,98 : 1921-1927.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部